Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. [electronic resource]
Producer: 20170116Description: 351-64 p. digitalISSN:- 1557-8224
- Angiotensin Receptor Antagonists -- therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Anti-Obesity Agents -- therapeutic use
- Anticholesteremic Agents -- therapeutic use
- Antioxidants -- therapeutic use
- Cannabinoid Receptor Antagonists -- therapeutic use
- Cholagogues and Choleretics -- therapeutic use
- Fatty Acids, Omega-3 -- therapeutic use
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin Resistance
- Lactones -- therapeutic use
- Metformin -- therapeutic use
- Non-alcoholic Fatty Liver Disease -- drug therapy
- Orlistat
- Pentoxifylline -- therapeutic use
- Piperidines -- therapeutic use
- Probiotics -- therapeutic use
- Pyrazoles -- therapeutic use
- Rimonabant
- Synbiotics
- Thiazolidinediones -- therapeutic use
- Ursodeoxycholic Acid -- therapeutic use
- Vitamin E -- therapeutic use
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.